Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells

Area of Science:

• Environmental toxicology
• Molecular carcinogenesis
• Cell biology

Background:

• Arsenic, a metalloid, exhibits biphasic effects on cells, promoting proliferation and carcinogenesis at low doses.
• Chromosomal aberrations are common in individuals exposed to arsenic.
• Overexpression of Aurora-A, a mitotic kinase, is linked to chromosomal instability and cell transformation.

Purpose of the Study:

• To elucidate the mechanism by which low-dose arsenic induces carcinogenesis through Aurora-A activation.
• To investigate the role of Aurora-A in arsenic-mediated cell proliferation and chromosomal instability.

Main Methods:

• Cell proliferation assays (BrdU, MTT, flow cytometry).
• Gene and protein expression analysis (RT-PCR, Western blotting).
• Centrosome observation (immunofluorescence).
• Transcription factor analysis (promoter activity, ChIP, shRNA).
• In vivo mouse model.

Main Results:

• Low-dose arsenic increased cell proliferation and S-phase accumulation.
• Arsenic exposure elevated Aurora-A mRNA and protein levels.
• Overexpressed Aurora-A led to increased multiple centrosomes.
• E2F1 was identified as the transcription factor responsible for arsenic-induced Aurora-A overexpression.
• In vivo studies confirmed increased Aurora-A expression and cell proliferation in mice exposed to arsenic.

Conclusions:

• Low-dose arsenic induces cell proliferation via Aurora-A overexpression, transcriptionally regulated by E2F1.
• This study presents a novel mechanism for arsenic-induced carcinogenesis at low concentrations.